TISSUE MALIGNANT TUMOR DETECTION METHOD AND TISSUE MALIGNANT TUMOR DETECTION APPARATUS

• US 20120136255A1
• Filed: 06/03/2011
• Published: 05/31/2012
• Est. Priority Date: 06/07/2010
• Status: Abandoned Application

• Current Assignee: Konica Minolta Inc.
• Original Assignee: Konica Minolta Inc.
• Inventors: Fan, Shu Feng, Tran, Anh Tuan, Chong, Kok Seng
• Application Number:
  US13/388,561
• Publication Number:
  US 20120136255A1
• Time in Patent Office: Days
• US Class Current: 600/443
• CPC Class Codes: A61B 8/02 Measuring pulse or heart rate
• CPC Class Codes: A61B 8/0833 involving detecting or locating foreign bodies or organic structures
• CPC Class Codes: A61B 8/485 involving measuring strain or elastic properties
• CPC Class Codes: A61B 8/5269 involving detection or reduction of artifacts for image enhancement algorithms G06T5/00

Abstract

To detect a malignant tumor more accurately by detecting a feature of a cancerous tumor pulsation more appropriately, a tissue malignant tumor detection method according to the present invention includes: segmenting, into blocks, a region scanned with ultrasound (S100); estimating, based on a scan signal, a tissue pulsation that is a temporal variation in tissue displacement derived from pulsations of a tissue (S101); extracting, for each of the blocks, pulsation-related features that are parameters related to the tissue pulsation (S103); calculating distribution characteristics of the pulsation-related features for each of the blocks (S104); and classifying, based on the distribution characteristics, whether or not each of the blocks is a malignant block that is a block including the malignant tumor (S105).

Claims

1-31. -31. (canceled)

32. A tissue malignant tumor detection apparatus which detects a malignant tumor included in a tissue, using a scan signal obtained by scanning the tissue with ultrasound, said tissue malignant tumor detection apparatus comprising:

a block segmentation unit configured to segment a scanned region of the tissue into a plurality of blocks;

a tissue pulsation estimation unit configured to estimate a tissue pulsation for each of the blocks, based on the scan signal, the tissue pulsation being a temporal variation in displacement of the tissue caused by pulsation of the tissue;

a pulsation-related feature extraction unit configured to extract a plurality of pulsation-related features for each of the blocks, the pulsation-related features being parameters related to the tissue pulsation;

a distribution characteristics calculation unit configured to calculate distribution characteristics of the pulsation-related features for each of the blocks; and

a malignancy classification unit configured to classify, based on the distribution characteristics, whether or not each of the blocks is a malignant block that is a block including a malignant tumor.

33. The tissue malignant tumor detection apparatus according to claim 32,

wherein said malignancy classification unit includes a tumor localization unit configured to locate a position of the malignant tumor, based on a block classified as the malignant block.

34. The tissue malignant tumor detection apparatus according to claim 32,

wherein said tissue pulsation estimation unit includes:

a tissue displacement calculation unit configured to calculate a tissue displacement using the scan signal, the tissue displacement being a displacement of the tissue in spatial position;

a tissue skewness calculation unit configured to calculate tissue skewness from the calculated tissue displacement, the tissue skewness being a spatial gradient of the tissue displacement; and

a pulsation waveform generation unit configured to generate a pulsation waveform that is a waveform of the tissue pulsation and indicates the tissue displacement versus time or the tissue skewness versus time.

35. The tissue malignant tumor detection apparatus according to claim 32, further comprising

a pre-processing unit configured to extract, from the estimated tissue pulsation, a component due to a cardiac pulsation derived from pulsations of a heart.

36. The tissue malignant tumor detection apparatus according to claim 35,

wherein said pre-processing unit further includes:

a cardiac power calculation unit configured to calculate, of the estimated tissue pulsation, cardiac power that is electric power related to the cardiac pulsation;

a cardiac pulsation clustering unit configured to cluster the scanned region of the tissue, based on a magnitude of the cardiac power;

an extrema identification unit configured to identify an extremum of an amplitude of the cardiac pulsation in the scanned region of the tissue that is clustered; and

a cardiac pulsation adjustment unit configured to adjust an amplitude of a pulsation waveform that is a waveform of the tissue pulsation, based on the extremum.

37. The tissue malignant tumor detection apparatus according to claim 36,

wherein said extrema identification unit further includes:

an extremum point identification unit configured to identify peaks and troughs in the pulsation waveform; and

an outlier rejection unit configured to reject an outlier in the amplitude of the pulsation waveform, so as to eliminate an interference peak and an interference trough, the interference peak being a peak with which a gap from another peak is larger than a predetermined threshold, and the interference trough being a trough with which a gap from another trough is larger than a predetermined threshold.

38. The tissue malignant tumor detection apparatus according to claim 36,

wherein said pre-processing unit further includes:

an interference elimination unit configured to eliminate portions related to an interference peak and an interference trough, the interference peak being a peak with which a gap from another peak is larger than a predetermined threshold, and an interference trough being a trough with which a gap from another trough is larger than a predetermined threshold; and

a pulsation adjustment unit configured to adjust the amplitude of the pulsation waveform so that the peaks in the pulsation waveform are aligned in a temporal direction and the troughs in the pulsation waveform are aligned in the temporal direction.

39. The tissue malignant tumor detection apparatus according to claim 32,

wherein said tissue pulsation estimation unit is configured to estimate the tissue pulsation for all scan points in each of the blocks.

40. The tissue malignant tumor detection apparatus according to claim 32,

wherein said tissue pulsation estimation unit is configured to estimate the tissue pulsation as at least one representative pulsation for each of the blocks or a combination of the at least one representative pulsation.

41. The tissue malignant tumor detection apparatus according to claim 32,

wherein the pulsation-related features include at least one of:

a pulsation amplitude feature that is a feature quantity related to an amplitude of the tissue pulsation;

a pulsation shape feature that is a feature quantity related to a shape of a waveform of the tissue pulsation; and

a pulsation temporal feature that is a feature quantity related to a temporal variation of the waveform of the tissue pulsation.

42. The tissue malignant tumor detection apparatus according to claim 41,

wherein the pulsation shape feature is at least one of:

L1/L2 which is a ratio between L1 that is a systolic duration and L2 that is a diastolic duration, the systolic duration being a duration of a systolic part of a cardiac cycle, and the diastolic duration being a duration of a diastolic part of the cardiac cycle;

L3/L4 which is a ratio between L3 that is a period from a systolic mid-point to a diastolic mid-point and L4 that is a duration of a cardiac pulsation, the systolic mid-point being a point at which, on a systolic curve, a ratio of the amplitude with respect to a maximum amplitude equals a predetermined ratio in the systolic duration, and the diastolic mid-point being a point at which, on a diastolic curve, a ratio of the amplitude with respect to the maximum amplitude equals a predetermined ratio in the diastolic duration;

a deviation of the diastolic curve from a predetermined curve connecting a systolic peak that is a peak in the amplitude in the systolic duration and a diastolic ending point that is an ending point of the diastolic duration;

skewness which represents asymmetry of the cardiac pulsation;

kurtosis which represents peakedness of the systolic peak; and

a deviation of an extremum included in the diastolic curve.

43. The tissue malignant tumor detection apparatus according to claim 41,

wherein the pulsation shape feature is calculated by a shape feature calculation unit which includes:

a cardiac pulsation duration calculation unit configured to calculate a cardiac cycle from the tissue pulsation;

a critical point identification unit configured to identify a critical point using the cardiac cycle; and

a shape feature extraction unit configured to extract the pulsation shape feature based on the cardiac cycle and the critical point.

44. The tissue malignant tumor detection apparatus according to claim 43,

wherein the critical point of the cardiac cycle includes:

a systolic starting point which is a starting point of a systolic part of the cardiac cycle;

a diastolic ending point which is an ending point of a diastolic part of the cardiac cycle;

a systolic peak which is a peak in the amplitude during the systolic part;

a systolic mid-point which is a point at which, on a systolic curve, a ratio of the amplitude with respect to a maximum amplitude equals a predetermined ratio during the systolic part of the cardiac cycle; and

a diastolic mid-point which is a point at which, on a diastolic curve, a ratio of the amplitude with respect to a maximum amplitude equals a predetermined ratio during the diastolic part of the cardiac cycle.

45. The tissue malignant tumor detection apparatus according to claim 43,

wherein said critical point identification unit includes:

a search unit configured to search a minimum point and a maximum point in the tissue pulsation;

a pulsation direction identification unit configured to identify a pulsation direction which indicates whether the tissue pulsation has an upward systolic curve or a downward systolic curve, based on the minimum point and the maximum point; and

a critical point determination unit configured to determine the critical point in the pulsation waveform, using the maximum point, the minimum point, and the pulsation direction.

46. The tissue malignant tumor detection apparatus according to claim 42,

wherein the predetermined curve is linear.

47. The tissue malignant tumor detection apparatus according to claim 42,

wherein said pulsation-related feature extraction unit is configured to calculate the deviation as a sum of positive differences between the diastolic curve and the predetermined curve when the pulsation has an upward systolic curve, and calculate the deviation as a sum of negative differences between the diastolic curve and the predetermined curve when the pulsation has a downward systolic curve.

48. The tissue malignant tumor detection apparatus according to claim 41,

wherein the pulsation temporal feature is at least one of:

a delay of a cardiac cycle;

a difference in a cardiac waveform that is a waveform of a cardiac pulsation; and

an autoregressive coefficient of a waveform of the tissue pulsation.

49. The tissue malignant tumor detection apparatus according to claim 48,

wherein the delay of the cardiac cycle is calculated by a cardiac cycle delay calculation unit which includes:

a reference cardiac cycle determination unit configured to determine a reference cardiac cycle that is a cardiac cycle to be referenced; and

a delay calculation unit configured to calculate a delay of a target cardiac cycle with respect to the reference cardiac cycle.

50. The tissue malignant tumor detection apparatus according to claim 49,

wherein said reference cardiac cycle determination unit is configured to select a cardiac cycle having a largest amplitude among scan data, as the reference cardiac cycle.

51. The tissue malignant tumor detection apparatus according to claim 49,

wherein the reference cardiac cycle is determined from an electrocardiography (ECG) signal.

52. The tissue malignant tumor detection apparatus according to claim 50,

wherein the difference in the cardiac waveform is calculated by said delay calculation unit which includes:

a reference cardiac waveform calculation unit configured to calculate a reference cardiac waveform that is a cardiac waveform to be referenced;

an individual difference calculation unit configured to calculate a difference between each of a plurality of cardiac waveforms derived from the pulsation and the reference cardiac waveform; and

a total difference calculation unit configured to calculate a total cardiac waveform difference value from a plurality of differences each of which is the calculated difference, the total cardiac waveform difference value being a value representing the differences between the cardiac waveforms and the reference cardiac waveform.

53. The tissue malignant tumor detection apparatus according to claim 52,

wherein the total cardiac waveform difference value is a standard deviation of the calculated differences.

54. The tissue malignant tumor detection apparatus according to claim 48,

wherein the autoregressive coefficient is calculated by an autoregressive coefficient calculation unit which includes:

a pulsation resampling unit configured to taper a plurality of pulsation waveforms to have the same cardiac cycle; and

an autoregressive formula calculation unit configured to calculate the autoregressive coefficient which is a coefficient of a predetermined autoregressive model, based on the predetermined autoregressive model and the tapered pulsation waveforms.

55. The tissue malignant tumor detection apparatus according to claim 32,

wherein the distribution characteristics are at least one of a spatial distribution parameter and a statistical distribution parameter.

56. The tissue malignant tumor detection apparatus according to claim 55,

wherein the spatial distribution parameter is at least one of energy, entropy, contrast, homogeneity, and correlation of the pulsation-related features.

57. The tissue malignant tumor detection apparatus according to claim 55,

wherein the statistical distribution parameter is at least one of a mean, a median, a largest value, a smallest value, a standard deviation, kurtosis, and skewness of the pulsation-related features.

58. The tissue malignant tumor detection apparatus according to claim 32,

wherein the pulsation-related features and the distribution characteristics of the pulsation-related features include at least one of:

a median, entropy, a standard deviation, a mean, and a largest value of the pulsation amplitude at a plurality of scan points in each of the blocks;

a median, entropy, a standard deviation, a mean, and a largest value of a cardiac waveform difference at the scan points in each of the blocks;

a median of a ratio between a systolic duration and a diastolic duration at the scan points in each of the blocks, the systolic duration being a duration of a systolic part of a cardiac cycle, and the diastolic duration is being a duration of a diastolic part of the cardiac cycle;

a ratio between the systolic duration and the diastolic duration of a representative pulsation in each of the blocks; and

a largest deviation value and a standard deviation of a diastolic curve at the scan points in each of the blocks.

59. The tissue malignant tumor detection apparatus according to claim 33,

wherein said tumor localization unit further includes:

a target region specification unit configured to set a target region for each of scan points in the scanned tissue;

a tumor block segmentation unit configured to identify a block belonging to the target region, from among the blocks; and

a cancer probability calculation unit configured to calculate a probability of the tissue being a cancer, based on a result of the classification performed by said malignancy classification unit on the block belonging to the target region.

60. The tissue malignant tumor detection apparatus according to claim 59,

wherein said tumor localization unit further includes:

an imaging unit configured to display, in two or three dimensional image, the probability of the tissue being a cancer at the scan points in the scanned tissue.

61. A tissue malignant tumor detection method for detecting a malignant tumor included in a tissue, using a scan signal obtained by scanning the tissue with ultrasound, said tissue malignant tumor detection method comprising:

segmenting a scanned region of the tissue into a plurality of blocks;

estimating a tissue pulsation for each of the blocks, based on the scan signal, the tissue pulsation being a temporal variation in displacement of the tissue caused by pulsation of the tissue;

extracting a plurality of pulsation-related features for each of the blocks, the pulsation-related features being parameters related to the tissue pulsation;

calculating distribution characteristics of the pulsation-related features for each of the blocks; and

classifying, based on the distribution characteristics, whether or not each of the blocks is a malignant block that is a block including a malignant tumor.

62. A non-transitory computer-readable recording medium on which a program for causing a computer to execute the tissue malignant tumor detection method according to claim 61 is recorded.